177 related articles for article (PubMed ID: 6967051)
1. Inhibition of immune complex-mediated activation of complement. Effects of agents modulating activation of, and the activated C1 complex.
Fletcher DS; Lin TY
Inflammation; 1980 Mar; 4(1):113-23. PubMed ID: 6967051
[TBL] [Abstract][Full Text] [Related]
2. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
[TBL] [Abstract][Full Text] [Related]
3. FN-C1q and C1 INH C1r-C1s complexes as indicators of complement activation in patients with chronic lymphocytic leukaemia.
Hidvégi T; Ermolin GA; Efremov EE; Dikov MM; Kurmanova LV; Vnashenkova GV; Merkulova MV; Kókai M; Panya A; Füst G
Immunol Lett; 1989 Jul; 22(1):1-6. PubMed ID: 2550362
[TBL] [Abstract][Full Text] [Related]
4. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles.
Kovacsovics TJ; Peitsch MC; Kress A; Isliker H
J Immunol; 1987 Mar; 138(6):1864-70. PubMed ID: 3029222
[TBL] [Abstract][Full Text] [Related]
5. The first component of human complement (C1): activation and control.
Ziccardi RJ
Springer Semin Immunopathol; 1983; 6(2-3):213-30. PubMed ID: 6314572
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of (C1INH)2 C1r-C1s complexes in glomerulonephritis as an indicator of C1 activation.
Waldo FB; West CD
Clin Immunol Immunopathol; 1987 Feb; 42(2):239-49. PubMed ID: 3026704
[TBL] [Abstract][Full Text] [Related]
7. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
[TBL] [Abstract][Full Text] [Related]
8. The role of immune complexes in the activation of the first component of human complement.
Ziccardi RJ
J Immunol; 1984 Jan; 132(1):283-8. PubMed ID: 6317744
[TBL] [Abstract][Full Text] [Related]
9. The relationship between the binding ability and the rate of activation of the complement component C1.
Folkerd EJ; Gardner B; Hughes-Jones NC
Immunology; 1980 Sep; 41(1):179-85. PubMed ID: 7429549
[TBL] [Abstract][Full Text] [Related]
10. Antibody density on rat red cells determines the rate of activation of the complement component C1.
Hughes-Jones NC; Gorick BD; Howard JC; Feinstein A
Eur J Immunol; 1985 Oct; 15(10):976-80. PubMed ID: 2996908
[TBL] [Abstract][Full Text] [Related]
11. C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes.
Sim RB; Arlaud GJ; Colomb MG
Biochem J; 1979 Jun; 179(3):449-57. PubMed ID: 475762
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
Katz Y; Strunk RC
J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
[TBL] [Abstract][Full Text] [Related]
13. A molecular mechanism for the activation of the first component of complement by immune complexes.
Schumaker VN; Hanson DC; Kilchherr E; Phillips ML; Poon PH
Mol Immunol; 1986 May; 23(5):557-65. PubMed ID: 3018553
[TBL] [Abstract][Full Text] [Related]
14. C1 activation and dissociation in disease.
Laurell AB; Mårtensson U; Sjöholm AG
Immunol Lett; 1987 Feb; 14(3):249-53. PubMed ID: 3032782
[TBL] [Abstract][Full Text] [Related]
15. Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.
Hack CE; Eerenberg-Belmer AJ; Lim UG; Haverman J; Aalberse RC
Arthritis Rheum; 1984 Jan; 27(1):40-8. PubMed ID: 6318777
[TBL] [Abstract][Full Text] [Related]
16. Activation of the first component of human complement (C1) by antibody-antigen aggregates.
Dodds AW; Sim RB; Porter RR; Kerr MA
Biochem J; 1978 Nov; 175(2):383-90. PubMed ID: 743203
[TBL] [Abstract][Full Text] [Related]
17. C1 subcomponent complexes: basic and clinical aspects.
Laurell AB; Sjöholm AG
Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
[TBL] [Abstract][Full Text] [Related]
18. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
Laurell AB; Mårtensson U; Sjöholm AG
J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
[TBL] [Abstract][Full Text] [Related]
19. Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s.
Doekes G; van Es LA; Daha MR
J Immunol; 1983 Oct; 131(4):1924-9. PubMed ID: 6604753
[TBL] [Abstract][Full Text] [Related]
20. The influence of classical pathway components during alternative pathway--modulated immune complex aggregation: the role of C1 INH.
Gronski P; Bodenbender L; Kanzy EJ; Seiler FR
Behring Inst Mitt; 1984 Nov; (76):29-41. PubMed ID: 6335396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
